Can acupuncture boost lung cancer treatment? new trial aims to find out

NCT ID NCT07337096

Recruiting now Disease control Sponsor: Guangzhou University of Traditional Chinese Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding electro-acupuncture to standard first-line treatment (PD-1 inhibitors plus chemotherapy) helps people with metastatic non-small cell lung cancer. About 424 participants will receive either real or sham acupuncture alongside their cancer therapy. The main goal is to see if acupuncture can delay disease progression and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Electro-acupuncture plus PD-1 inhibitors and chemotherapy
What this could lead to: If it works, this could show that adding acupuncture to standard cancer treatment improves how long the disease stays under control and reduces side effects.
What could go wrong: This is an early-stage trial with no phase designation, so results are uncertain. Acupuncture is a complementary therapy and may not meaningfully improve outcomes; the sham control helps test if any benefit is due to placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACCUPUNCTURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACCUPUNCTURE NON-SMALL CELL LUNG CANCER PD-1 INHIBITORS

Contacts and locations

Locations

Guangdong Provincial Hospital of Chinese Medicine
RECRUITING

Guangzhou, Guangdong, 34830, China
Jiangsu Provincial Hospital of Chinese Medicine
RECRUITING

Nanjing, Jiangsu, 210000, China
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
RECRUITING

Guangzhou, Guangdong, 510000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.